Table 1.
Nucleotide change † | cDNA | Genomic DNA | ||||||
---|---|---|---|---|---|---|---|---|
Patients | Mutations * | Normal | Variant | Enzyme site change | location ‡ | # clones variant/total | exon location § | # clones variant/total |
GF | A270V | C(GCG) | C(GTG) | BstUI lost | 809 | 12/17 | 7 | 3/5 |
C590R | (TGT) | (CGT) | none | 1768 | 9/22 | 13 | 3/4 | |
HM | A341P | GTCA(GCC) | GTCA(CCC) | Tsp45I created | 1021 | 10/10 | 9 | 3/6 |
C534* | C(TGC)G | C(TGA)G | DdeI created | 1602 | – | 12 | – | |
TB | R593C | (CGT) | (TGT) | none | 1777 | 3/3 | 13 | – |
Mutations in the CD18 protein sequence. The initiation methionine is assigned number ‘1’.
Mutations in the cDNA sequence. For clarity, the DNA sequences and numbering are shown in italics. The altered bases are shown in bold and the codons involved are in brackets. Where restriction enzyme sites are affected, the sequences are shown and underlined.
The location of the altered nucleotides in the cDNA sequence. The ‘A’ in the initiation codon ‘ATG’ is assigned number ‘1’.
Exon locations are assigned according to Weitzman et al. [20].